Dapagliflozin cuts cardiovascular activities in patients with coronary heart failure, T2D

Dapagliflozin cuts cardiovascular activities in patients with coronary heart failure, T2D

For individuals with heart failure and type 2 diabetic issues (T2D), dapagliflozin does not reduce urinary albumin-to-creatinine ratio (UACR) but does decrease some cardiovascular situations, in accordance to a examine posted on the web Nov. 27 in eClinicalMedicine…
Read More

You May Also Like